All lobbying filings

SMITHBUCKLIN CORPORATION

Lobbying for ASTCT · Healthcare Society

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$70,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 7

Centers For Disease Control & Prevention (CDC)
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Natl Institutes of Health (NIH)
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 8

HR 1509
Accelerating Kids’ Access to Care Act of 2025
S 752
Accelerating Kids’ Access to Care Act
HR 2491
ABC Act
S 1227
ABC Act
HR 5160
Stem Cell Therapeutic and Research Reauthorization Act of 2025
S 4109
Stem Cell Therapeutic and Research Reauthorization Act of 2026
HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025

Lobbying activity 3

Health Issues

Labor-HHS Appropriations Billing and Coding classifications CAR-T Therapy Clarifications Revaccination of Immunosuppressed Patients H.R. 1509/S. 752, The Accelerating Kids Access to Care Act H.R. 2491/S. 1227, Alleviating Barriers to Care Act H.R. 5160/S.4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 H.R.1262/S.932, the Give Kids a Chance Act

Medicare/Medicaid

- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - H.R. 1509/S. 752, the Accelerating Kids Access to Care Act - H.R. 2491/S. 1227, the Alleviating Barriers to Care Act

Medical/Disease Research/Clinical Labs

- Labor-HHS Appropriations - CAR-T Therapy clarification

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.